Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma.
Antifungal Therapy with Itraconazole Impairs the Anti-Lymphoma Effects of Rituximab by Inhibiting Recruitment of CD20 to Cell Surface Lipid. J Pediatr Hematol Oncol. 2006 Jan;28133-5. Itraconazole-enhanced chemotherapy toxicity in a patient with Hodgkin lymphoma. Bashir H1, Motl S, Metzger. Could Itraconazole cause Lymphoma? We studied 6993 Itraconazole users who have side effects from FDA and eHealthme. Among them, 21 have Lymphoma.
Itraconazole-enhanced chemotherapy toxicity in a. - NCBI - NIH
Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has. in vitro and in vivo using a murine xenograft model of lymphoma, to abrogate. A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma. In our current work, we define and characterize the anticancer activity of itraconazole in preclinical rituximab-sensitive or -resistant lymphoma.
Will you have Lymphoma with Itraconazole - from FDA reports.
View detailed reports from patients taking itraconazole who experienced lymphoma. Reports are from official medical reports as well as online extractions from. The authors describe the clinical course of a boy with Hodgkin lymphoma who developed severe myelosuppression and neurotoxicity after the concurrent.
Role of itraconazole in haematology/oncology - NCBI
Infection in children with acute leukaemia and lymphoma during induction therapy. Med Paediatr Oncol 1999;4–8. 6 Grant SM, Clissold SP. Itraconazole. Abstract. Background Among B-cell lymphoma, double hit lymphoma DHL is defined by a MYC/8q24 combined with another recurrent.